Display options
Cite
Cai X, Peng D, Wei H, et al. miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncol Lett. 2017;13(4):2349-2353doi: 10.3892/ol.2017.5692.
Cai, X., Peng, D., Wei, H., Yang, X., Huang, Q., Lin, Z., Xu, W., Qian, M., Yang, C., Liu, T., Yan, W., & Zhao, J. (2017). miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncology letters, 13(4), 2349-2353. https://doi.org/10.3892/ol.2017.5692
Cai, Xiaopan, et al. "miR-215 suppresses proliferation and migration of non-small cell lung cancer cells." Oncology letters vol. 13,4 (2017): 2349-2353. doi: https://doi.org/10.3892/ol.2017.5692
Cai X, Peng D, Wei H, Yang X, Huang Q, Lin Z, Xu W, Qian M, Yang C, Liu T, Yan W, Zhao J. miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncol Lett. 2017 Apr;13(4):2349-2353. doi: 10.3892/ol.2017.5692. Epub 2017 Feb 07. PMID: 28454402; PMCID: PMC5403480.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Apr;13(4):2349-2353. doi: 10.3892/ol.2017.5692. Epub 2017 Feb 07.

miR-215 suppresses proliferation and migration of non-small cell lung cancer cells.

Oncology letters

Xiaopan Cai, Dongyu Peng, Haifeng Wei, Xinghai Yang, Quan Huang, Zaijun Lin, Wei Xu, Ming Qian, Cheng Yang, Tielong Liu, Wangjun Yan, Jian Zhao

Affiliations

  1. Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China.

PMID: 28454402 PMCID: PMC5403480 DOI: 10.3892/ol.2017.5692

Abstract

The expression of microRNA-215 (miR-215) in non-small cell lung cancer (NSCLC) tissues and the effects of miR-215 on the proliferation and migration of NSCLC cells were investigated. qRT-PCR was used to detect the expression of miR-215 in NSCLC tissues and paired normal tumor-adjacent lung tissues; MTT assay, transwell assay and soft-agar assay were used

Keywords: lung cancer; miR-215; microRNA; migration; non-small cell lung cancer

References

  1. Cancer Cell. 2006 Mar;9(3):189-98 - PubMed
  2. Pharmacogenomics. 2015;16(15):1751-60 - PubMed
  3. Cancer Lett. 2015 Feb 1;357(1):196-205 - PubMed
  4. Oncotarget. 2015 Sep 22;6(28):25024-33 - PubMed
  5. Exp Ther Med. 2012 Jan;3(1):149-153 - PubMed
  6. Clin Cancer Res. 2001 Jan;7(1):5-22 - PubMed
  7. Mol Cancer. 2010 Apr 30;9:96 - PubMed
  8. Radiol Clin North Am. 2012 Sep;50(5):863-76 - PubMed
  9. Clin Colorectal Cancer. 2011 Dec;10 (4):340-7 - PubMed
  10. BMC Cancer. 2013 Oct 08;13:464 - PubMed
  11. Rev Mal Respir. 2009 Sep;26(7):769-72 - PubMed
  12. Cancer Cell. 2008 Jan;13(1):48-57 - PubMed
  13. Oncotarget. 2016 Jan 26;7(4):4817-28 - PubMed
  14. Mayo Clin Proc. 2008 May;83(5):584-94 - PubMed
  15. Med Oncol. 2014 Nov;31(11):259 - PubMed
  16. Cancer Lett. 2014 May 28;347(1):65-74 - PubMed
  17. Clin Lung Cancer. 2009 Jan;10(1):42-6 - PubMed
  18. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1524-9 - PubMed
  19. Br J Cancer. 2011 Nov 22;105(11):1741-9 - PubMed
  20. Ann Transl Med. 2016 Apr;4(8):150 - PubMed
  21. Oncol Rep. 2016 Mar;35(3):1816-22 - PubMed
  22. J Thorac Oncol. 2013 Aug;8(8):1095-101 - PubMed

Publication Types